Ann Arbor, MI (PRWEB) September 10, 2008
Donald Nease, Jr., MD, Chief Medical Officer for Cielo MedSolutions, authored a paper in Medical Care entitled "Impact of a Generalizable Reminder System on Colorectal Cancer Screening in Diverse Primary Care Practices." The paper reports on a study evaluating ClinfoTracker - the technology on which Cielo Clinic™ is based - using historical control data in twelve community-based, primary care practices distributed across Michigan.
Average screening rates at the beginning of the study were at 41.7 percent. By the end of the study, that rate had jumped to 66.5 percent.
Despite high levels of awareness among primary care physicians of the recommendations for colorectal cancer screening, rates of screening remain just over 60 percent in the U.S. according to the Centers for Disease Control and Prevention (CDC).
"The work of this study is important as a baseline for practices implementing reminder systems, especially those not ready for full electronic health record systems," said Dr. Nease. "This study was in many ways the impetus to commercialize ClinfoTracker by licensing the technology to Cielo MedSolutions."
This work was funded by National Cancer Institute/Agency for Healthcare Research and Quality "Colorectal Cancer Screening in Primary Care Practice" program grant R21 CA104484.
About Cielo MedSolutions
Cielo MedSolutions (pronounced "see EL oh," Spanish for sky or heaven - http://www.cielomedsolutions.com) is a rapidly-growing provider of healthcare software and Web applications. Headquartered in Ann Arbor, Michigan, Cielo is pioneering a new category of healthcare IT known as clinical quality management systems (CQMS). The company's web-based Cielo Clinic™ software-as-a-service (SaaS) offering helps ambulatory care providers proactively improve, document and report on clinical care and supports initiatives such as patient-centered medical homes, pay-for-performance programs, clinical integration, quality improvement and clinical scorecarding.